AKT signaling in control of ATL tumorigenicity; unveiled mechanism for its heterogenous activation among ATL cell populations
Project/Area Number |
15K06848
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Tumor biology
|
Research Institution | Miyagi Prefectural Hospital Organization Miyagi Cancer Center |
Principal Investigator |
Yamaguchi Kazunori 地方独立行政法人宮城県立病院機構宮城県立がんセンター(研究所), 発がん制御研究部, 上席主任研究員 (80373215)
|
Research Collaborator |
Sugamura Kazuo
Nasu Kentaro
Takanashi Tomoka
|
Project Period (FY) |
2015-04-01 – 2019-03-31
|
Project Status |
Completed (Fiscal Year 2018)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | 成人T細胞白血病 / AKTシグナル / AKT |
Outline of Final Research Achievements |
Human retrovirus HTLV-1 is an etiological agent for Adult T-cell leukemia/lymphoma (ATL), but additional cellular events such as aberrant modulation of signal transduction taking place for several decades after the initial HTLV-1 infection are totally unveiled. Previously we obtained highly tumorigenic populations of ATL-derived ST1 and TL-Om1 cells and found these cell populations exhibited an activated AKT signaling pathway, which may contribute to the malignancy observed in the ATL-derived cells. In this study we analyzed molecular mechanism underlying upregulation of AKT signaling in the highly tumorigenic ATL cells and found that PIK3IP1 and INPP5D, negative regulators for AKT signaling, are both inactivated in these cells. In addition, our observations suggest that activating phosphorylation of AKT might be accomplished by atypical kinase(s) in ATL cells.
|
Academic Significance and Societal Importance of the Research Achievements |
HTLV-1ウイルス感染者は西日本を中心に数十万から百万人程度で、この内の5%程度がATLを発症すると推定されている。発症後の治療法として骨髄移植と抗CCR4抗体治療が知られているが適用の年齢制限や抵抗性などの問題があり、新たな治療法の開発が望まれている。本研究はATL悪性化の一因としてAKTシグナル伝達系の活性化に着目し、その分子機構の解明を試みたもので、その成果は新たな治療戦略への寄与が期待される。
|
Report
(5 results)
Research Products
(20 results)
-
-
-
-
-
-
[Journal Article] Crucial role of carbonic anhydrase IX in tumorigenicity of xenotransplanted adult T-cell leukemia-derived cells.2017
Author(s)
Nasu K, Yamaguchi K, Takanashi T, Tamai K, Sato I, Ine S, Sasaki O, Satoh K, Tanaka N, Tanaka Y, Fukushima T, Harigae H, Sugamura K.
-
Journal Title
Cancer Sci
Volume: 108
Issue: 3
Pages: 435-443
DOI
NAID
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
-
-
[Journal Article] CD271 regulates the proliferation and motility of hypopharyngeal cancer cells2016
Author(s)
Mochizuki M, Tamai K, Imai T, Sugawara S, Ogama N, Nakamura M, Matsuura K, Yamaguchi K, Satoh K, Sato I, Motohashi H, Sugamura K, Tanaka N
-
Journal Title
Sci Rep
Volume: 6
Issue: 1
Pages: 30707-30707
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Xenotransplantation elicits salient tumorigenicity of adult T-cell leukemia-derived cells via aberrant AKT activation.2016
Author(s)
Yamaguchi K, Takanashi T, Nasu K, Tamai K, Mochizuki M, Satoh I, Ine S, Sasaki O, Satoh K, Tanaka N, Harigae H, Sugamura K.
-
Journal Title
Cancer Sci.
Volume: ePub
Issue: 5
Pages: 638-643
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
[Journal Article] Identification of TL-Om1, an ATL Cell Line, as a Reference Material for Human T-Lymphotropic Virus 1 Quantitative PCR.2015
Author(s)
Kuramitsu M, Okuma K, Yamagishi M, Yamochi T, Firouzi S, Momose H, Mizukami T, Takizawa K, Araki K, Sugamura K, Yamaguchi K, Watanabe T, Hamaguchi I.
-
Journal Title
Journal of Clinical Microbiology
Volume: 53
Issue: 2
Pages: 587-596
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
-
-
-
-
-
-
-